HOPKINTON, Mass. – September 5, 2019 – (Newswire.com)
Isto Biologics, an orthobiologics company dedicated to improving patient quality of life, announced today the release of Influx Demineralized Bone Matrix (DBM) Putty. The addition of this product commences the growth of Isto Biologic’s existing Influx portfolio, a line of advanced allograft technology that delivers regenerative capacity in a versatile human bone graft.
Influx DBM is a fully moldable, demineralized bone graft that utilizes proprietary processing of demineralized cortical fibers and demineralized cortical particulate to produce a positive osteoinductive response (1). The introduction of this new product provides doctors a pre-hydrated graft option that is ready-to-use directly out of the packaging — with no need for graft preparation or rehydration. This new product is part of the existing Influx allograft portfolio that also offers Influx Demineralized Cortical Fibers — an advanced allograft that combines the regenerative capacity of interconnected fibers with the availability of growth factors. 
Isto Biologics is devoted to delivering best-in-class products to physicians through novel solutions for cell-based therapy and rapid bone healing. The Influx portfolio coincides with Isto Biologic’s Magellan® Autologous Concentration System and InQu®, our cell-friendly biosynthetic bone graft extender and substitute. As Isto Biologics continues to prioritize the importance of assisting surgeons to help their patients heal faster, the development and growth of the new Influx offering will bring another innovative solution. “Isto’s mission is to deliver products that enable Physicians to help patients heal faster. Through the advancements in our products, such as the latest Influx DBM Putty, we continue to deliver on this goal,” said Nate Taylor, Vice President of Sales and Marketing of Isto Biologics.
About Isto Biologics
Isto Biologics was formed in 2016 when St. Louis-based Isto Technologies and Arteriocyte Medical Systems Inc. of Hopkinton, Massachusetts, merged under the Isto Holdings umbrella. Isto Biologics is focused on Helping Patients Heal FasterTM, through its innovative solutions for bone regeneration and cell-based therapies. The company’s flagship product offerings include the market-leading Magellan® autologous platelet separator and bone-growth products, including InQu® Bone Graft Extender & Substitute and Influx, a natural bone-graft material.
To learn more about Influx DBM Putty, Click Here.
Reference: 1. Data on file, DCI Donor Services Tissue Bank
Related Links
Isto Biologics Website
Influx Product Page